dChan
Anonymous ID: 0a581d Feb. 9, 2020, 6:30 p.m. No.8086930   🗄️.is 🔗kun

(Fashion. Just like Hollywood. Another way the left influences art and fashion culture)

 

The Cast at Dior Sported Plaits Like Climate Change Activist Greta Thunberg

 

With the climate at the top of everyone’s agenda, Maria Grazia Churi’s move to send out her model cast in Greta Thunberg plaits was a stroke of genius.

 

From the #MeToo movement to the student protests of ‘60s Paris, the Dior creative director is known for championing a cause, infusing activism into her collections with zeal. But the climate cause in no way detracts from the fact that spring ‘20 was far and away her best collection to date.

 

https://footwearnews.com/2019/runway/spring-2020/pfw-dior-spring-2020-ready-to-wear-collection-1202844594/

Anonymous ID: 0a581d Feb. 9, 2020, 6:36 p.m. No.8086997   🗄️.is 🔗kun   >>7214

(Is this the "bridge" Q told us about?)

 

BRIDGE PHAMACEUTICALS & Gavin Newsom:

 

Bridge Pharmaceuticals yesterday dedicated its recently completed Bridge Zhongguancun Preclinical Drug Development Laboratory I.

 

In attendance at the ceremony were: San Francisco Mayor Gavin Newsom; Deputy Mayor Beijing Municipal Office Hao Lu; Beijing Deputy Mayor Bo-Yuan Fan; US Embassy Senior Commercial Officer Craig Allen; Former Beijing Deputy Mayor Zhao-Guang Hu; Director of Beijing Municipal Industrial Development Bureau Lian-Yuan Cheng; Director of Beijing Municipal Science Technology Office Hai Feng; and Former San Francisco Mayor Frank Jordon.

 

This 7,800 square meter facility puts Bridge at the forefront of preclinical outsourcing to China and will be the first and only US level GLP and AAALAC designed facility in China. The Zhongguancun facility will house primates, rodents, canines, rabbits. Services will include: FDA compliant GLP toxicology, pharmacology, predictive PK/ADMET, safety pharmacology, formulation and other services. Through its Vital Bridge joint venture, Bridge has expert local partners in China that provide animal supplies from the largest and only US-franchised (Charles River and Marshall Farms) quality animal breeding facilities in China.

 

For Bridge, the opening of this facility marks the next phase in outsourcing preclinical drug development to Asia. By controlling its own facility in China, Bridge will have the capacity and expertise to provide FDA compliant preclinical drug development services to pharmaceutical and biotech companies throughout the world. This new facility positions Bridge as the leading preclinical CRO in China targeting US and EU biopharmaceutical companies.

 

"The San Francisco Bay Area is the birthplace of biotech and has remained the worldwide leader in life sciences innovation. Escalation of the price of drugs, as evidenced by California's recent ballot initiative, is an increasing hardship and concern," said San Francisco Mayor Gavin Newsom.

 

http://www.fogcityjournal.com/news_in_brief/bridge_pharm_051128.shtml